Status:
RECRUITING
The Biomarkers in the Hyperbaric Oxygen Brain Injury Treatment Trial (BioHOBIT)
Lead Sponsor:
University of Michigan
Conditions:
Traumatic Brain Injury
Eligibility:
All Genders
16-65 years
Brief Summary
There are no therapeutic agents that have been shown to improve outcomes from severe traumatic brain injury (TBI). Critical barriers to progress in developing treatments for severe TBI are the lack of...
Detailed Description
The Investigators will obtain an initial set of biospecimens (serum, plasma, CSF, DNA) as soon as feasible after randomization to a HOBIT study arm, but no later than 24 hours from injury. Subsequent ...
Eligibility Criteria
Inclusion
- Enrolled in HOBIT (this is an ancillary study to the HOBIT Trial)
Exclusion
- Profoundly anemic (subjects who are profoundly anemic require blood transfusion)
- Blood samples cannot be obtained
Key Trial Info
Start Date :
January 19 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2027
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04855396
Start Date
January 19 2021
End Date
August 31 2027
Last Update
June 27 2025
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
UCSD Medical Center - Hillcrest Hospital
San Diego, California, United States, 92103
2
St. Mary's Medical Center
West Palm Beach, Florida, United States, 33407
3
University of Iowa Hospitals & Clinics
Iowa City, Iowa, United States, 52242
4
University of Kentucky Hospital
Lexington, Kentucky, United States, 40536